Louis-Marie Dourthe

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

Antoine Adenis, Christelle de la Fouchardière, Bernard Paule et al. · BMC Cancer · 2016 · 126 citations · Full text

Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study

Martin Boegemann, Sara Khaksar, G. Béra et al. · BMC Cancer · 2019 · 41 citations · Full text

Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies

Philippe Barthélémy, Irène Asmane-De la Porte, Nicolás Meyer et al. · Oncology · 2014 · 33 citations

699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers

Thomas Powles, Yohann Loriot, Joaquim Bellmunt et al. · Annals of Oncology · 2020 · 19 citations

Prognostic Biomarkers, Urology, Urologic Cancer Epidemiology +10